Revolution Medicines Inc at JPMorgan Healthcare Conference Transcript
Good morning. Thanks for joining us for another session at the 44th JPMorgan Healthcare Conference. I'm Brian Cheng. I'm one of the senior biotech analysts here at the firm. This is a highly anticipated presentation.
And we have the CEO from Rev Med, Mark Goldsmith. I will now pass the mic to Mark for a short presentation followed by a live audience Q&A. Mark, the stage is yours.
Thanks for the introduction, Brian, and good morning, everyone. It's really great to be here at the JPMorgan Healthcare Conference and to share an overview of Revolution Medicines. We've made meaningful progress and have a transformative year ahead of us.
As today's presentation will include forward-looking statements. Please refer to our legal disclaimer shown here on slide 2.
At Revolution Medicines, our mission is bold to revolutionize treatment globally for patients living with RAS-addicted cancers
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
